120 related articles for article (PubMed ID: 12022689)
1. Sequence-specific gene cleavage in intact mammalian cells by 125I-labeled triplex-forming oligonucleotides conjugated with nuclear localization signal peptide.
Sedelnikova OA; Karamychev VN; Panyutin IG; Neumann RD
Antisense Nucleic Acid Drug Dev; 2002 Feb; 12(1):43-9. PubMed ID: 12022689
[TBL] [Abstract][Full Text] [Related]
2. Antigene radiotherapy: targeted radiodamage with 125i-labeled triplex-forming oligonucleotides.
Panyutin IG; Sedelnikova OA; Karamychev VN; Neumann RD
Ann N Y Acad Sci; 2003 Dec; 1002():134-40. PubMed ID: 14751831
[TBL] [Abstract][Full Text] [Related]
3. Targeting the human mdr1 gene by 125I-labeled triplex-forming oligonucleotides.
Sedelnikova OA; Panyutin IG; Luu AN; Reed MW; Licht T; Gottesman MM; Neumann RD
Antisense Nucleic Acid Drug Dev; 2000 Dec; 10(6):443-52. PubMed ID: 11198928
[TBL] [Abstract][Full Text] [Related]
4. DNA binding and antigene activity of a daunomycin-conjugated triplex-forming oligonucleotide targeting the P2 promoter of the human c-myc gene.
Carbone GM; McGuffie E; Napoli S; Flanagan CE; Dembech C; Negri U; Arcamone F; Capobianco ML; Catapano CV
Nucleic Acids Res; 2004; 32(8):2396-410. PubMed ID: 15121897
[TBL] [Abstract][Full Text] [Related]
5. Use of polyethylenimine-adenovirus complexes to examine triplex formation in intact cells.
Hoque AT; Sedelnikova OA; Luu AN; Swaim WD; Panyutin IG; Baum BJ
Antisense Nucleic Acid Drug Dev; 2000 Aug; 10(4):229-41. PubMed ID: 10984117
[TBL] [Abstract][Full Text] [Related]
6. Development of DNA-based radiopharmaceuticals carrying Auger-electron emitters for antigene radiotherapy.
Sedelnikova OA; Luu AN; Karamychev VN; Panyutin IG; Neumann RD
Int J Radiat Oncol Biol Phys; 2001 Feb; 49(2):391-6. PubMed ID: 11173132
[TBL] [Abstract][Full Text] [Related]
7. DNA damage produced by 125I-triplex-forming oligonucleotides as a measure of their successful delivery into cell nuclei.
Panyutin IV; Sedelnikova OA; Bonner WM; Panyutin IG; Neumann RD
Ann N Y Acad Sci; 2005 Nov; 1058():140-50. PubMed ID: 16394133
[TBL] [Abstract][Full Text] [Related]
8. Development of DNA-based radiopharmaceuticals carrying Auger-electron emitters for anti-gene radiotherapy.
Panyutin IG; Winters TA; Feinendegen LE; Neumann RD
Q J Nucl Med; 2000 Sep; 44(3):256-67. PubMed ID: 11105589
[TBL] [Abstract][Full Text] [Related]
9. Antigene and antiproliferative effects of a c-myc-targeting phosphorothioate triple helix-forming oligonucleotide in human leukemia cells.
McGuffie EM; Pacheco D; Carbone GM; Catapano CV
Cancer Res; 2000 Jul; 60(14):3790-9. PubMed ID: 10919652
[TBL] [Abstract][Full Text] [Related]
10. Induction of the chromosomal translocation t(14;18) by targeting the BCL-2 locus with specific binding I-125-labeled triplex-forming oligonucleotides.
Dahmen V; Schmitz S; Kriehuber R
Mutat Res Genet Toxicol Environ Mutagen; 2017 Nov; 823():58-64. PubMed ID: 28985947
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxic effects and specific gene expression alterations induced by I-125-labeled triplex-forming oligonucleotides.
Dahmen V; Kriehuber R
Int J Radiat Biol; 2012 Dec; 88(12):972-9. PubMed ID: 22694342
[TBL] [Abstract][Full Text] [Related]
12. Head-to-head bis-hairpin polyamide minor groove binders and their conjugates with triplex-forming oligonucleotides: studies of interaction with target double-stranded DNA.
Halby L; Ryabinin VA; Sinyakov AN; Novopashina DS; Venyaminova AG; Grokhovsky SL; Surovaya AN; Gursky GV; Boutorine AS
J Biomol Struct Dyn; 2007 Aug; 25(1):61-76. PubMed ID: 17676939
[TBL] [Abstract][Full Text] [Related]
13. Iodine-125-labeled DNA-Triplex-forming oligonucleotides reveal increased cyto- and genotoxic effectiveness compared to Phosphorus-32.
Dahmen V; Pomplun E; Kriehuber R
Int J Radiat Biol; 2016 Nov; 92(11):679-685. PubMed ID: 27022855
[TBL] [Abstract][Full Text] [Related]
14. Sequence-specific DNA breaks produced by triplex-directed decay of iodine-125.
Panyutin IG; Neumann RD
Acta Oncol; 1996; 35(7):817-23. PubMed ID: 9004758
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of (111)In-labeled triplex-forming oligonucleotide targeting human N-myc gene.
Cho JG; Kim MK; Oh EJ; Yoon EJ; Sohn J; Park MK; Park GH
Mol Cells; 2002 Aug; 14(1):93-100. PubMed ID: 12243359
[TBL] [Abstract][Full Text] [Related]
16. Sequence-specific DNA double-strand breaks induced by triplex forming 125I labeled oligonucleotides.
Panyutin IG; Neumann RD
Nucleic Acids Res; 1994 Nov; 22(23):4979-82. PubMed ID: 7800489
[TBL] [Abstract][Full Text] [Related]
17. Peptide conjugates for chromosomal gene targeting by triplex-forming oligonucleotides.
Rogers FA; Manoharan M; Rabinovitch P; Ward DC; Glazer PM
Nucleic Acids Res; 2004; 32(22):6595-604. PubMed ID: 15602001
[TBL] [Abstract][Full Text] [Related]
18. An efficient antigene activity and antiproliferative effect by targeting the Bcl-2 or survivin gene with triplex forming oligonucleotides containing a W-shaped nucleoside analogue (WNA-βT).
Taniguchi Y; Sasaki S
Org Biomol Chem; 2012 Oct; 10(41):8336-41. PubMed ID: 22987068
[TBL] [Abstract][Full Text] [Related]
19. Triplex-forming oligonucleotides can modulate aquaporin-5 gene expression in epithelial cells.
Delporte C; Panyutin IG; Sedelnikova OA; Lillibridge CD; O'Connell BC; Baum BJ
Antisense Nucleic Acid Drug Dev; 1997 Oct; 7(5):523-9. PubMed ID: 9361911
[TBL] [Abstract][Full Text] [Related]
20. Improved synthesis of daunomycin conjugates with triplex-forming oligonucleotides. The polypurine tract of HIV-1 as a target.
Capobianco ML; De Champdoré M; Arcamone F; Garbesi A; Guianvarc'h D; B Arimondo P
Bioorg Med Chem; 2005 May; 13(9):3209-18. PubMed ID: 15809156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
